Toxicologie des tryptamines (notice n° 1614805)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02750cam a2200289 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20260111070816.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Moutaouakkil, Youssef |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Toxicologie des tryptamines |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2026.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 12 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Depuis l’an 2000, les nouveaux produits de synthèse (NPS), également appelées designer drugs ou legal highs, ont considérablement transformé le paysage des produits stupéfiants. Elles servent généralement d’alternative légale aux substances psychoactives réglementées et contrôlées. Les tryptamines occupent une place importante parmi ces NPS, et ont, à ce titre, signalées au système d’alerte précoce de l’Union européenne. La propagation de ces substances implique l’utilisation de nouvelles technologies de communication, influençant l’offre sur le marché et orientant la demande des consommateurs. Les fabricants, trafiquants et fournisseurs de ces NPS s’ajustent constamment au marché pour contourner les mesures de contrôle et d’interdiction mises en place par les autorités nationales et internationales compétentes. Ce travail examine les aspects pharmacologiques, historiques, épidémiologiques, toxicologiques et analytiques des cathinones. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Since 2000, newly reported synthetic products (NPS), also known as “designer drugs” or “legal highs”, have significantly reshaped the drug landscape. These substances typically serve as legal alternatives to regulated and controlled psychoactive compounds. Tryptamines play a significant role among the NPS in the European Union’s early warning system. The dissemination of these substances involves the use of new communication technologies, influencing market supply and shaping consumer demand. Manufacturers, traffickers, and suppliers of these NPS continually adapt to the market to circumvent control and prohibition measures implemented by competent national and international authorities. This work explores the pharmacological, historical, epidemiological, toxicological, and analytical aspects of cathinones. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | nouvelles drogues de synthèse |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | nouvelles substances psychoactives |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | tryptamines |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | new psychoactive substances |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | new synthetic drugs |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | tryptamines |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | El Cadi, Mina Ait |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lamsaouri, Jamal |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bousliman, Yassir |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | ElJaoudi, Rachid |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Cahiers Santé Médecine Thérapeutique | 34 | 6 | 2026-01-06 | p. 418-422 | 2780-8858 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://stm.cairn.info/revue-cahiers-sante-medecine-therapeutique-2025-6-page-418?lang=fr&redirect-ssocas=7080">https://stm.cairn.info/revue-cahiers-sante-medecine-therapeutique-2025-6-page-418?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux